丹参川芎嗪注射液治疗脑血栓应用价值及效果评析

2015-12-02 20:50:33边玲李利关会林
中外医疗 2015年29期
关键词:临床疗效

边玲 李利 关会林

[摘要] 目的 探讨丹参川芎嗪注射液在脑血栓临床治疗中的价值与效果。方法 整群收集2013年1月—2015年1月,该院收治的脑血栓患者74例,随机分为观察组与对照组,各37例。对照组应用血塞通注射液治疗,观察组在对照组的基础上加用丹参川芎嗪注射液进行治疗,比较两组的疗效。 结果 观察组的治疗总有效率为94.59%,显著高于对照组的81.08%(P<0.05);治疗后两组的NIHSS评分均显著降低,且观察组的降低幅度更为显著(P<0.05)。 结论 丹参川芎嗪注射液治疗脑血栓能够有效改善患者的神经功能,提高临床疗效,值得推广应用。

[关键词] 脑血栓;丹参川芎嗪注射液;临床疗效

[中图分类号] R743.3 [文献标识码] A [文章编号] 1674-0742(2015)10(b)-0029-03

Evaluation of the Value and Effect of Salvia TMP Injection in the Treatment of Cerebral Thrombosis

BIAN Ling1, LI Li2, GUAN Hui-lin3

1.Department of Neurology, Shuangyashan City People's Hospital, Shuangyashan, Heilongjiang Province, 155510 China;2.Department of Neurosurgery, Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150000 China;3.Pharmacology Teaching and Research Section, Mudanjiang Medical University, Mudanjiang, Heilongjiang Province, 157011 China

[Abstract] Objective To investigate the value and clinical effect of Salvia TMP Injection in the treatment of cerebral thrombosis. Methods 74 patients with cerebral thrombosis admitted in our hospital from January 2013 to January 2015 were selected and randomly divided into the observation group and the control group with 37 cases in each. Both groups were treated by Sanqi Panax Notoginseng Injection, and the observation group was given Salvia TMP Injection additionally. And the efficacy was compared between the two groups. Results The overall response rate was much higher in the observation group than that in the control group(94.59% vs 81.08%)(P<0.05). After treatment, the NIHSS scores decreased in both groups, and the reduction of NIHSS scores in the observation group was greater(P<0.05). Conclusion For patients with cerebral thrombosis, Salvia TMP Injection can effectively improve the nerve function and the clinical outcome, which is worthy of extensive application and promotion.

[Key words] Cerebral thrombosis; Salvia TMP Injection; Clinical efficacy

脑血栓是临床常见脑血管疾病之一,主要是由于脑动脉主干或者其皮质支动脉发生粥样硬化,引起血管壁增厚、血管管腔狭窄、闭塞以及形成血栓等,从而导致脑组织局部血流量减少甚至血供中断,进而导致脑组织严重缺氧、缺血、软化和坏死,并诱发不同程度的神经功能障碍[1]。血塞通及丹参川芎嗪注射液均是临床治疗脑血栓的常用药物,该院对脑血栓患者在应用血塞通的基础上加用丹参川芎嗪注射液治疗,旨在研究丹参川芎嗪注射液对于脑血栓治疗的价值,现报道如下。

1 资料与方法

1.1 一般资料

整群收集2013年1月—2015年1月,该院收治的脑血栓患者74例,均经临床表现、病史询问、头颅CT或者腰椎穿刺检查确诊。患者随机分为观察组与对照组,37例每组。观察组中,男15例,女22例,年龄50~78岁,平均(66.97±3.69)岁;病灶部位:27例基底节区,3例枕叶,7例颞叶。对照组中,男18例,女19例,年龄55-80岁,平均(67.12±3.97)岁;病灶部位:25例基底节区,3例枕叶,9例颞叶。两组年龄、性别与病灶部位差异无统计学意义(P>0.05)。

登录APP查看全文

猜你喜欢
临床疗效
针药复合麻醉用于腹腔镜胆囊切除术患者中的临床有效性分析
今日健康(2016年12期)2016-11-17 12:55:34
微创去腐技术治疗龋齿的临床疗效评价
今日健康(2016年12期)2016-11-17 11:53:45
复方去氧孕烯片治疗人工流产术后月经不调的疗效分析
今日健康(2016年12期)2016-11-17 11:36:14
CRRT在重症胰腺炎中的应用及护理
核苷类药物治疗乙型肝炎肝硬化失代偿期的效果研究
黄葵胶囊联合缬沙坦治疗糖尿病肾病临床疗效
探讨氯吡格雷预防冠心病介入治疗心血管的临床疗效
131碘治疗甲亢患者的后期随访效果分析
枸橼酸咖啡因治疗早产儿原发性呼吸暂停临床分析
微创手术治疗胃溃疡42例临床分析